top of page
Search

DEA Ryan Haight Rule Updates

Writer: DNP Consulting DNP Consulting
Mar 13, 20232 min read

Updated: Mar 17, 2023

The DEA has come out with its 'purposed rules" for how the prescribing of controlled substances will look after the Public Health Emergency ends on May 11, 2023.


The new telehealth restrictions proposed by the Drug Enforcement Administration (DEA) last week struck a sour chord with several industry stakeholders. Many industry insiders condemned the move as out of touch and even dangerous, jeopardizing telehealth models’ effectiveness in behavioral health.


Still, the proposal is not set in stone, and parts of it could change after it goes through its public comment phase.


Some industry experts, including DNP Consulting, say that the DEA is out of compliance with a long-standing mandate to create a special registration process to allow some providers to prescribe controlled substances via telehealth without in-person exams. This special registration was to be implemented back in 2008 with the creation of the RH rule.



Still, the initial proposed rules could change before it becomes effective, with some industry observers seeing the austere proposal as more of a starting place for discussion than an intentional walk-back of telehealth use in prescribing controlled substances.


The DEA will hold a 30-day public comment period for the proposed rule that expires on March 31.


Key takeaways

  • The proposed rules would require patients to undergo an in-person examination before clinicians can prescribe controlled substances virtually.

  • The DEA said that if an in-person visit is not conducted prior to a telehealth visit, providers may prescribe:

    • a maximum 30-day supply of Schedule III to V non-narcotics; and

    • a maximum 30-day supply of buprenorphine for opioid use disorder.

  • Providers may also prescribe controlled substances via telehealth without conducting an in-person visit if the patient was referred by a DEA-licensed provider who previously saw the patient in person.

  • The DEA said the rules will not apply to telehealth consultations that do not involve controlled substances.

The public will be able to comment on the proposed changes until March 31. Comments can be submitted HERE or HERE

It is imperative that all providers comment on how these restricted rules will negatively impact their patient populations. DNP Consulting will be sure to keep you all up to date as soon as we know more.





 
 
 

Comments

© 2024 DNP Consulting, LLC | Collaborative Physician Partners, LLC

​

Collaborative Physician Partners (CPP) is a headhunting, recruiting, and payroll company, and DNP Consulting is a Healthcare Management Services Organization (MSO). None of the information contained here constitutes legal, accounting, or medical advice. The information presented is informational and intended to serve as a reference for interested parties and not to be relied upon as authoritative. Your personal legal and financial counsel or healthcare providers should be consulted as appropriate. 

 

All healthcare providers affiliated with CPP are in the independent private practice of medicine or nursing. All CPP affiliates are solely and exclusively in control of the provision of professional medical services. CPP will neither have nor exercise any control or discretion over the methods by which the Providers practice medicine or nursing. CPP will in no way be construed to alter or otherwise affect the legal, ethical, or professional relationships between and among the Providers, Affiliates, and their patients, nor does anything in this Agreement abrogate any right, privilege, or obligation arising from or related to the Provider-Patient relationship.

 

All content found on this website was created for informational purposes only.  The content is not intended to be a substitute for professional medical and/or legal advice.  Always seek the advice of your medical provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking treatment because of something you have read on this website or any website. Collaborative Physician Partners, LLC, DNP Consulting, LLC, their respective staff, employees, contractors, or owners do not personally recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this website and related forums. Reliance on any information provided by this website, employees, contractors, or medical professionals presenting content for publication is solely at your own risk.

bottom of page